People

Rachel McMinn

Founder and chief executive officer of Neurogene and executive chair of its board. Founded the neurological gene therapy company in January 2018. Previously chief business and strategy officer at Intercept Pharmaceuticals and a biotechnology analyst. Holds a Cornell bachelor's degree and a Scripps Research Institute PhD, followed by a Berkeley Miller fellowship.